Disease: human colon and rectal cancer
NumberOfSamples: 65 colorectal cancer (CRC) cell lines
NumberOfSamples: 90 CRC patients
NumberOfSamples: 52 CRC cell lines
NumberOfSamples: 1,074 CRC tumours
CellLine: SW480
CellLine: HDC‐135
CellLine: CC07
CellLine: HDC‐143
CellLine: SK‐CO‐1
CellLine: C10
CellLine: CaCo‐2
CellLine: T84
CellLine: LS 180
CellLine: OXCO‐1
CellLine: RKO
CellLine: HDC‐111
CellLine: HT55
CellLine: C125‐PM
Instrument: Orbitrap Velos mass spectrometer
Instrument: Orbitrap Elite mass spectrometer
Instrument: Dionex Ultimate 3000 HPLC system
EnrichmentMethod: Kinobeads
SampleTreatment: acetone precipitation
CleavageAgent: trypsin (Roche)
ReductionReagent: DTT
AlkylationReagent: chloroacetamide
FragmentationMethod: higher‐energy collisional dissociation (HCD)
IonizationType: positive ion mode
CollisionEnergy: 30% normalised collision energy
PrecursorMassTolerance: 4.5 ppm
FragmentMassTolerance: 0.4 Da
FlowRateChromatogram: 250 μl/min
GradientTime: 24 min
GradientTime: 13 min
NumberOfFractions: 24 fractions
BiologicalReplicate: biological triplicates
ConcentrationOfCompound: 1% Pen‐Strep
ConcentrationOfCompound: penicillin at 100 units/ml
ConcentrationOfCompound: streptomycin at 100 μg/ml final concentration
ConcentrationOfCompound: 10% foetal bovine serum (FBS, SLI EU‐000F Batch 503005)
ConcentrationOfCompound: 10 mM DTT
ConcentrationOfCompound: 55 mM chloroacetamide
ConcentrationOfCompound: 20 mM Tris–HCl pH 7.5
ConcentrationOfCompound: 1 mM EDTA
ConcentrationOfCompound: 100 mM NaCl
ConcentrationOfCompound: 1% Triton X‐100
ConcentrationOfCompound: 0.5% sodium deoxycholate
ConcentrationOfCompound: 0.1% SDS
Compound: RIPA100 buffer
Compound: urea buffer
ConcentrationOfCompound: 40 mM Tris–HCl pH = 7.6
ConcentrationOfCompound: 8 M urea
Separation: hydrophilic strong anion exchange (hSAX) chromatography
AssayName: in vitro cell viability assays
Temperature: 37°C
Temperature: 4°C
Temperature: 275°C
Time: 5 min
Time: 72 h